Fischer Chemic informs about outcome of board meeting

04 May 2024 Evaluate
Fischer Chemic has informed that the Board of Directors of Fischer Medical Ventures (Formerly known as Fischer Chemic) (‘the Company’) in its meeting held at the Registered Office of the Company on Saturday 04th May 2024 have inter-alia considered and approved the following amongst other items: Subsequent to successful completion of the open offer made by Time Medical International Ventures Pte Ltd (Acquirer-1), Shankar Varadharajan (Acquirer-2) and Ravindran Govindan (Acquirer-3) (hereinafter collectively referred to as the Acquirers) in accordance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulation, 2011, the Board of Directors induced the Acquirers as the new promoters of the Company; Considered and took on records the resignation of Dilip Suryakant Jha as the Director of the Company with effect from closure of Business hours on 04th May 2024 and he shall continue as the Chief Financial officer of the Company. Further, details required under Regulation 30 of SEBI Listing Regulations, 2015, are given as Annexure-I.; On the recommendations of the Nomination Remuneration Committee have approved the appointment of Ravindran Govindan (DIN: 03137661) as Chairman and Managing Director of the Company for a term of Five years from 04th May 2024 subject to approval of shareholders in the ensuing Postal Ballot Process. Further, details required under Regulation 30 of SEBI Listing Regulations, 2015, are given as Annexure-II.

The above information is a part of company’s filings submitted to BSE.

Fischer Medical Share Price

631.80 -1.05 (-0.17%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1069.40
SRF 2165.85
Pidilite Inds. 2958.60
Aarti Inds 430.80
Atul 7261.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.